Imuran and Macrodantin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Imuran and Macrodantin. Common interactions include impaired healing among females.

The phase IV clinical study analyzes what interactions people who take Imuran and Macrodantin have. It is created by eHealthMe based on reports of 13 people who take Imuran and Macrodantin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 22, 2022

13 people who take Imuran and Macrodantin together, and have interactions are studied.


What is Imuran?

Imuran has active ingredients of azathioprine. It is often used in crohn's disease. eHealthMe is studying from 30,094 Imuran users for its effectiveness, alternative drugs and more.

What is Macrodantin?

Macrodantin has active ingredients of nitrofurantoin, macrocrystalline. It is often used in urinary tract infection. eHealthMe is studying from 3,530 Macrodantin users for its effectiveness, alternative drugs and more.

Number of Imuran and Macrodantin reports submitted per year:

Imuran and Macrodantin drug interactions.

Common Imuran and Macrodantin drug interactions by gender *:

female:

  1. Impaired healing
  2. Injection site pain
  3. Drug hypersensitivity
  4. Faeces discoloured
  5. Fibromyalgia
  6. Flatulence
  7. Gastrointestinal inflammation
  8. Headache
  9. Hypothyroidism
  10. Injection site swelling

male:

n/a

Common Imuran and Macrodantin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Cervical dysplasia
  2. Unintended pregnancy

30-39:

  1. Accident
  2. Constipation
  3. Dehydration
  4. Multiple sclerosis
  5. Weight decreased

40-49:

n/a

50-59:

  1. Autoimmune hepatitis
  2. Cardiac murmur
  3. Gastritis
  4. Impaired healing
  5. Pain in jaw
  6. Tooth abscess

60+:

  1. Abdominal discomfort
  2. Abdominal pain
  3. Multiple sclerosis relapse
  4. Proteus infection
  5. Abdominal pain upper
  6. Diarrhoea
  7. Faeces discoloured
  8. Flatulence
  9. Headache
  10. Abnormal faeces

Common conditions people have *:

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 30.77%
  2. Pain: 4 people, 30.77%
  3. Osteoporosis (bones weak and more likely to break): 3 people, 23.08%
  4. Asthma: 3 people, 23.08%
  5. Sleep Disorder: 2 people, 15.38%
  6. Diarrhea: 2 people, 15.38%
  7. Chest Pain: 2 people, 15.38%
  8. Abdominal Pain: 2 people, 15.38%
  9. Neuropathy Peripheral (surface nerve damage): 1 person, 7.69%
  10. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Imuran and Macrodantin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Imuran and Macrodantin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Imuran interactions:

Browse all interactions between Imuran and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Macrodantin interactions:

Browse all interactions between Macrodantin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on azathioprine and nitrofurantoin, macrocrystalline (the active ingredients of Imuran and Macrodantin, respectively), and Imuran and Macrodantin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Imuran and Macrodantin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: